There is an increasing pressure on all companies and organisations carrying out animal testing to find and use suitable alternative non-animal methods wherever possible. While alternative methods have been under development for some time… what is now becoming available for the many varied and different needs of users? Where can such methods be applied? Have they been validated? Will they be acceptable to the regulatory authorities? Can nanotechnology and other scientific advances be applied to this problem as it has successfully in fields like medicine? These questions and many others will be broached at the forthcoming international Conference “Nanotechnology – Towards reducing animal testing” to be held in the unique surroundings of the Royal Society in London on 28-29 May 2008. Key themes include:
- a review of some of the most promising human cell-based in vitro models
- novel lab-on-a-chip and bioreactor systems for screening, toxicology and targeting studies
- surface modification at the nanoscale to improve biosensors and in vitro test systems
- novel human tissue-based test models
- how the European Centre for the Validation of Alternative Methods (ECVAM) can help
The conference will be of particular interest to those involved in pharmaceutical, cosmetics and medical device development and testing; the safety evaluation of chemicals, e.g. the new REACH legislation; environmental and food testing; and regulation.
Conference speakers include:
Dr Fanqin Frank Chen (Lawrence Berkeley National Laboratory, USA); Dr Antonio Garcia (Arizona State University, USA); Dr Béatrice Schaack (CEA Grenoble, France); Dr Andy Bennett (FRAME Alternatives Laboratory, UK); Dr Peter Ertl, (Austrian Research Centers GmbH); Dr Sandra Coecke, (IHCP-ECVAM, Italy); Dr John Haycock (Kroto Research Institute, UK), Dr Rosemary Gibson (Health and Safety Laboratory, UK); Dr Ulrich Krühne (Teknologisk Institut, Denmark).
Register now! For online registration and payment visit https://www.nano.org.uk/payments/index.php.